Literature DB >> 3338523

Comparison of posttranslational protein modification by amino acid addition after crush injury to sciatic and optic nerves of rats.

S Shyne-Athwal1, G Chakraborty, E Gage, N A Ingoglia.   

Abstract

Posttranslational protein modifications by the addition of amino acids are reactions which occur in intact sciatic and optic nerves of rats. The nerves differ, however, in that 2 h after crush injury these reactions are activated in sciatic but not in optic nerves. As sciatic nerves will eventually regenerate, whereas optic nerves will not, we have proposed that the activation of these reactions is correlated with the ability of a nerve to regenerate. The current experiments examined the posttranslational addition of amino acids to proteins at times greater than 2 h after nerve crush, during sciatic nerve regeneration and optic nerve degeneration. We also examined the optic nerve for morphologic correlates to changes in protein modification and partially characterized the proteins modified by [3H]Lys in the regenerating sciatic nerve using two-dimensional sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). In a segment of sciatic nerve taken from a region just proximal to the site of crush, protein modification by covalent addition of [3H]Arg, [3H]Lys and [3H]Leu increased during both posttraumatic (2 h postcrush) and regenerative (6 days and 14 days postcrush) stages. Two-dimensional PAGE of [3H]Lys modified sciatic nerve proteins 6 days after crush injury showed labeling of proteins having molecular masses in the 18,000- to 20,000-, 30,000- to 40,000-, and 80,000- to 100,000-Da ranges, with neutral or basic isoelectric points (pI 7.1 to 8.0). In the retinal portion of the crushed optic nerve, incorporation of the same amino acids was unchanged or depressed to 21 days postcrush, except at 6 days postcrush when the incorporation of all three amino acids into proteins was increased threefold. These increases correlated with the appearance of terminal end bulbs in the portion of nerve analyzed. Histological examination of each nerve 2 h postcrush showed marked edema in the optic but not the sciatic nerve, a condition which may be related to the ability of sciatic and inability of optic nerves to activate protein modification reactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338523     DOI: 10.1016/0014-4886(88)90148-3

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

Review 1.  Posttranslational arginylation of brain proteins.

Authors:  M E Hallak; G Bongiovanni
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Isolation of a peptide that inhibits the posttranslational arginylation of proteins in rat brain.

Authors:  M Yu; M Grabow; N A Ingoglia
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

3.  N-terminal arginylation of sciatic nerve and brain proteins following injury.

Authors:  Y M Wang; N A Ingoglia
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

Review 4.  The role of local protein synthesis and degradation in axon regeneration.

Authors:  Laura F Gumy; Chin Lik Tan; James W Fawcett
Journal:  Exp Neurol       Date:  2009-06-09       Impact factor: 5.330

5.  N-terminal arginylation of proteins in explants of injured sciatic nerves and embryonic brains of rats.

Authors:  N S Xu; G Chakraborty; A Hassankhani; N A Ingoglia
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

6.  Posttranslational Arginylation Enzyme Arginyltransferase1 Shows Genetic Interactions With Specific Cellular Pathways in vivo.

Authors:  David J Wiley; Gennaro D'Urso; Fangliang Zhang
Journal:  Front Physiol       Date:  2020-05-06       Impact factor: 4.566

7.  Posttranslational arginylation enzyme Ate1 affects DNA mutagenesis by regulating stress response.

Authors:  Akhilesh Kumar; Michael D Birnbaum; Devang M Patel; William M Morgan; Jayanti Singh; Antoni Barrientos; Fangliang Zhang
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.